Real‐world analysis of the relationships between smoking, lung cancer stigma, and emotional functioning

Abstract

AbstractIntroductionPeople diagnosed with lung cancer experience high rates of distress, which can be compounded by the stigma of the disease. This study assessed a real‐world population to understand patient‐reported emotional functioning, types of stigma experienced, and relationship with smoking history.MethodsQuestionnaires using validated survey tools assessing demographics, smoking history, stigma, and quality of life (EORTC QLQ‐C30 Emotional Functioning Scale) were analyzed from 539 global participants in the Lung Cancer Registry between November 2019 and July 2022. The associations between smoking history and self‐reported internalized and perceived stigma and constrained disclosure of lung cancer diagnosis, as well as the potential impact of stigma on emotional functioning, were examined using multivariable logistic regression models.ResultsAmong the broad geographic mix of study participants, all types of lung cancer stigma were associated with decreased emotional functioning due to a combination of factors including depression, anxiety, stress, and irritability. Participants who reported a history of current or former smoking experienced higher levels of internalized stigma and perceived stigma. Constrained disclosure about a diagnosis was common, associated with decreased emotional functioning, and not related to a history of smoking. Smoking status itself was not associated with reduced emotional functioning, implicating the role of stigma in distress.ConclusionsIn this study, all types of lung cancer stigma were associated with clinically important decreases in emotional functioning. This impact was not dependent on smoking history. Internalized and perceived stigma were associated with the presence of a smoking history. These findings have implications for proper psychosocial care of people diagnosed with lung cancer.